Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
With a market cap of 8.69B, Corcept Therapeutics(CORT) trades at $82.65. The stock has a price-to-earnings ratio of 94.44.
On 2025-12-28, Corcept Therapeutics(CORT) stock traded between a low of $82.54 and a high of $84.97. Shares are currently priced at $82.65, which is +0.1% above the low and -2.7% below the high.
The Corcept Therapeutics(CORT)'s current trading volume is 341.85K, compared to an average daily volume of 1.22M.
During the past year, Corcept Therapeutics(CORT) stock moved between $49.00 at its lowest and $117.33 at its peak.
During the past year, Corcept Therapeutics(CORT) stock moved between $49.00 at its lowest and $117.33 at its peak.
CORT News
Earlier this week, Corcept Therapeutics faced heightened scrutiny as investors reacted to the upcoming U.S. FDA decision on relacorilant, a drug application sup...
The average one-year price target for Corcept Therapeutics (BIT:1CORT) has been revised to €106.49 / share. This is a decrease of 11.14% from the prior estimate...
